Castration-Resistant Prostate Cancer Refractory to Second-Generation Androgen Receptor Axis-Targeted Agents: Opportunities and Challenges

Second-generation androgen receptor axis-targeted (ARAT) agents, namely abiraterone and enzalutamide, enable stronger blockade of the androgen receptor (AR) axis and longer survival of men with castration-resistant prostate cancer (CRPC). However, the extent of the improved survival remains insuffic...

Descripción completa

Detalles Bibliográficos
Autores principales: Kita, Yuki, Goto, Takayuki, Akamatsu, Shusuke, Yamasaki, Toshinari, Inoue, Takahiro, Ogawa, Osamu, Kobayashi, Takashi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6210307/
https://www.ncbi.nlm.nih.gov/pubmed/30248934
http://dx.doi.org/10.3390/cancers10100345

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6210307/
https://www.ncbi.nlm.nih.gov/pubmed/30248934
http://dx.doi.org/10.3390/cancers10100345

Ejemplares similares